chr15-80152846-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001374380.1(FAH):c.-30+5G>C variant causes a splice donor 5th base, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.22 ( 3820 hom., cov: 17)
Exomes 𝑓: 0.27 ( 16380 hom. )
Consequence
FAH
NM_001374380.1 splice_donor_5th_base, intron
NM_001374380.1 splice_donor_5th_base, intron
Scores
2
Splicing: ADA: 0.00008294
2
Clinical Significance
Conservation
PhyloP100: -0.875
Genes affected
FAH (HGNC:3579): (fumarylacetoacetate hydrolase) Predicted to enable fumarylacetoacetase activity. Predicted to be involved in L-phenylalanine catabolic process; homogentisate catabolic process; and tyrosine catabolic process. Predicted to act upstream of or within arginine catabolic process. Located in extracellular exosome. Implicated in tyrosinemia type I. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 15-80152846-G-C is Benign according to our data. Variant chr15-80152846-G-C is described in ClinVar as [Benign]. Clinvar id is 1258417.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAH | NM_001374377.1 | c.-89G>C | 5_prime_UTR_variant | 1/15 | |||
FAH | NM_001374380.1 | c.-30+5G>C | splice_donor_5th_base_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAH | ENST00000407106.5 | c.-89G>C | 5_prime_UTR_variant | 1/15 | 5 | P1 | |||
FAH | ENST00000558767.6 | c.-209G>C | 5_prime_UTR_variant | 1/5 | 2 | ||||
FAH | ENST00000261755.9 | c.-30+5G>C | splice_donor_5th_base_variant, intron_variant | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.221 AC: 29273AN: 132498Hom.: 3825 Cov.: 17
GnomAD3 genomes
AF:
AC:
29273
AN:
132498
Hom.:
Cov.:
17
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.269 AC: 114666AN: 425690Hom.: 16380 Cov.: 2 AF XY: 0.268 AC XY: 60393AN XY: 225562
GnomAD4 exome
AF:
AC:
114666
AN:
425690
Hom.:
Cov.:
2
AF XY:
AC XY:
60393
AN XY:
225562
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.221 AC: 29278AN: 132582Hom.: 3820 Cov.: 17 AF XY: 0.218 AC XY: 13957AN XY: 64128
GnomAD4 genome
AF:
AC:
29278
AN:
132582
Hom.:
Cov.:
17
AF XY:
AC XY:
13957
AN XY:
64128
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at